These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 9676778
1. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma. Ford AL, Kurien BT, Harley JB, Scofield RH. J Rheumatol; 1998 Jul; 25(7):1419-24. PubMed ID: 9676778 [Abstract] [Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y. J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [Abstract] [Full Text] [Related]
3. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047 [Abstract] [Full Text] [Related]
4. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La. Pillemer SR, Casciola-Rosen L, Baum BJ, Rosen A, Gelber AC. J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924 [Abstract] [Full Text] [Related]
5. [Primary biliary cirrhosis (PBC)-CREST overlap syndrome complicated with Sjögren's syndrome]. Akiyama Y, Suzuki T, Tanaka M, Fujimaki T, Asaoka T, Kobayashi K, Ohno S, Imai F, Matuo H. Ryumachi; 1997 Feb; 37(1):42-7. PubMed ID: 9128423 [Abstract] [Full Text] [Related]
6. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis. Vázquez-Abad D, Grodzicky T, Senécal JL. Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829 [Abstract] [Full Text] [Related]
7. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis]. Onozuka Y, Shibata M, Yonezawa H, Terauti K, Miyachi K, Ueno Y. Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074 [Abstract] [Full Text] [Related]
8. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F. J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261 [Abstract] [Full Text] [Related]
9. [Anti-centromere antibodies. Study of 67 positive sera]. Renier G, Le Normand I, Chevailler A, Verret JL, Renier JC, Hurez D. Rev Med Interne; 1992 Nov; 13(6):413-4, 417-8. PubMed ID: 1344922 [Abstract] [Full Text] [Related]
10. The heterogeneity of anticentromere antibodies in immunoblotting analysis. Muro Y, Sugimoto K, Okazaki T, Ohashi M. J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779 [Abstract] [Full Text] [Related]
12. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon. Kremer L, Alvaro-Gracia JM, Ossorio C, Avila J. Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807 [Abstract] [Full Text] [Related]
13. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Russo K, Hoch S, Dima C, Varga J, Teodorescu M. J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030 [Abstract] [Full Text] [Related]
14. Primary biliary cirrhosis (PBC)-CREST (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia) overlap syndrome complicated by Sjögren's syndrome and arthritis. Ito M, Kojima T, Miyata M, Saka M, Kokubun M, Ohira H, Ishikawa H, Kuroda M, Sato Y, Takagi T. Intern Med; 1995 May; 34(5):451-4. PubMed ID: 7647420 [Abstract] [Full Text] [Related]
15. Anti-centromere antibodies in patients with systemic lupus erythematosus. Respaldiza N, Wichmann I, Ocaña C, Garcia-Hernandez FJ, Castillo MJ, Magariño MI, Magariño R, Torres A, Sanchez-Roman J, Nuñez-Roldan A. Scand J Rheumatol; 2006 May; 35(4):290-4. PubMed ID: 16882593 [Abstract] [Full Text] [Related]
16. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Ramos-Casals M, Nardi N, Brito-Zerón P, Aguiló S, Gil V, Delgado G, Bové A, Font J. Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154 [Abstract] [Full Text] [Related]
17. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen. Vázquez-Abad D, Wallace S, Senécal JL, Joyal F, Roussin A, Earnshaw WC, Rothfield N. Arthritis Rheum; 1994 Feb; 37(2):248-52. PubMed ID: 8129780 [Abstract] [Full Text] [Related]
18. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma. Drosos AA, Pennec YL, Elisaf M, Lamour A, Acritidis NC, Jouquan JR, Moutsopoulos HM, Youinou P. J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489 [Abstract] [Full Text] [Related]
19. Distinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma. Gelber AC, Pillemer SR, Baum BJ, Wigley FM, Hummers LK, Morris S, Rosen A, Casciola-Rosen L. Ann Rheum Dis; 2006 Aug; 65(8):1028-32. PubMed ID: 16414973 [Abstract] [Full Text] [Related]